Visão selecionada em Inglês
| Descritor em português: | Vidarabina | ||||||
| Descritor em inglês: | Vidarabine | ||||||
| Descritor em espanhol: |
Vidarabina
| ||||||
| Descritor em francês: | Vidarabine | ||||||
| Termo(s) alternativo(s): |
9 beta Arabinofuranosyladenine 9 beta D Arabinofuranosyladenine 9-beta-Arabinofuranosyladenine 9-beta-D-Arabinofuranosyladenine Adenine Arabinoside Ara A Ara-A Arabinofuranosyladenine Arabinoside, Adenine Arabinosyladenine Vira A Vira-A ViraA alpha Ara A alpha D Arabinofuranosyladenine alpha-Ara A alpha-D-Arabinofuranosyladenine beta Ara A beta-Ara A |
||||||
| Código(s) hierárquico(s): |
D03.633.100.759.590.138.900 D13.570.065.950 D13.570.583.138.900 |
||||||
| Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D014740 | ||||||
| Nota de escopo: | A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. |
||||||
| Nota de indexação: | an antiviral & antimetabolite |
||||||
| Qualificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Ação Farmacológica: |
Antimetabólitos Antivirais |
||||||
| Número de registro: | FA2DM6879K | ||||||
| Nome CAS Tipo 1: | 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl- | ||||||
| Indexação Anterior: |
Adenine (1972-1974) Arabinose (1972-1974) Nucleosides (1972-1974) Purines (1966-1973) |
||||||
| Nota MeSH pública: | 79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76 |
||||||
| Nota Online: | use VIDARABINE to search ARABINOFURANOSYLADENINE 1975-78 |
||||||
| Nota histórica: | 79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76 |
||||||
| Identificador DeCS: | 15144 | ||||||
| ID do descritor: | D014740 | ||||||
| Classificação da NLM: | QV 268.5 | ||||||
| Documentos indexados na Biblioteca Virtual em Saúde (BVS): | Clique aqui para acessar os documentos da BVS | ||||||
| Data de estabelecimento: | 01/01/1977 | ||||||
| Data de entrada: | 19/11/1974 | ||||||
| Data de revisão: | 24/05/2017 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Vidarabine
- Conceito preferido
Vira-A
- Mais específico
| Identificador do conceito |
M0022659 |
| Nota de escopo | A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. |
| Termo preferido | Vidarabine |
| Termo(s) alternativo(s) |
9 beta Arabinofuranosyladenine 9 beta D Arabinofuranosyladenine 9-beta-Arabinofuranosyladenine 9-beta-D-Arabinofuranosyladenine Adenine Arabinoside Ara A Ara-A Arabinofuranosyladenine Arabinoside, Adenine Arabinosyladenine alpha Ara A alpha D Arabinofuranosyladenine alpha-Ara A alpha-D-Arabinofuranosyladenine beta Ara A beta-Ara A |
| Identificador do conceito |
M0022660 |
| Termo preferido | Vira-A |
| Termo(s) alternativo(s) |
Vira A ViraA |
Queremos a sua opinião sobre o novo sitio web do DeCS/MeSH
Convidamos-lhe a responder a uma pesquisa que não levará mais que 3 minutos
Ir para pesquisa
